During the past decade, Centro de Pesquisas Clínicas em Oncología conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisas Clínicas em Oncología" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Pesquisas Clínicas em Oncología" are "Adenocarcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Centro de Pesquisas Clínicas em Oncología" in a lesser frequency.

Most popular intervention types in "Centro de Pesquisas Clínicas em Oncología" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "BIBW 2992" (2 trials), "Cisplatin" (2 trials), "Pemetrexed" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Pesquisas Clínicas em Oncología" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro de Pesquisas Clínicas em Oncología". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro de Pesquisas Clínicas em Oncología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Pesquisas Clínicas em Oncología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".